(805) 963-0439 | Toll-Free (800) 876-6425 LA / NY / UK

Cognition Studio, Inc.

Totus Covalent MOA 

Prev Next

Sana: Fusogen MOA animation

Next medical animation of TriSalus takes an integrated approach tailored to the target organ and disease biology to overcome two critical barriers: immunosuppression and delivery. This composite video tells the complexity of TriSalus' story by communicating the value of SD-101, a therapeutic that delivers organ-specific immunomodulation, and  SmartValve™ technology, a regional intravascular, Pressure-Enabled Drug Delivery approach to increase therapeutic value and support better patient outcomes.

TriSalus: SD-101 and SmartValve Technology

Covalent therapeutics are some of the most impactful in society yet make up only 2% of the market because, in the past, they have primarily been identified accidentally. The animation showcases that covalent bonding used in conjunction with Totus Medicines’ proprietary machine learning technology platform for high-throughput drug discovery converts genetic discoveries into real drugs, making more diseases treatable.

Keywords: Animation, 3D, Editorial, Biology, Biotechnology, Cell biology / Histology, Mechanism of Action (MOA)

Totus Medicines